Trials / Completed
CompletedNCT02149264
A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Male
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase 3, open-label, non-randomized, clinical trial to evaluate the efficacy and safety of FE 999303 (Testosterone gel) in adult hypogonadal males.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Testosterone gel (FE 999303) |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2015-05-01
- Completion
- 2015-06-01
- First posted
- 2014-05-29
- Last updated
- 2017-10-26
- Results posted
- 2017-07-28
Locations
22 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02149264. Inclusion in this directory is not an endorsement.